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The effects of high-fat feeding on physical function and skeletal
muscle extracellular matrix
CS Tam1, JE Power2, TP Markovic3, C Yee2, M Morsch4, SV McLennan2,5 and SM Twigg2,5
Skeletal muscle extracellular matrix (ECM) remodelling has been proposed as a feature of the pathogenic milieu associated with
obesity and metabolic dysfunction. Whether muscle ECM is associated with impaired physical function in obese conditions is
unknown. C57BL/6 mice were fed a high-fat diet (HFD) or chow for 5, 10 and 25 weeks. Non-invasive physiological tests (hang wire,
hang mesh and grip strength) to assess neuromuscular function and motor co-ordination were performed. Genes related to ECM
structure (COL1, COL3, COL6A2, SPARC), growth factors (TGFB1, TGFB2, CTGF, VEGF) and muscle function (DMD (Dp147), CPN3,
DAG1) were measured in gastrocnemius muscle using real-time PCR and COL1, 3 and 6 protein were measured by western
immunoblot. Compared with chow, HFD mice had two to six-fold lower muscle strength (hang wire test; raw data and multiplied
by body weight) at all time-points (Po0.001) and two-fold lower hang mesh and grip strength at 10 weeks (Po0.05). At 5 weeks,
COL1, COL3 and COL6 gene expression, but not protein levels were three to eight-fold lower in HFD compared with chow. In the
HFD group at 5 weeks, greater COL3 and 6 gene expression were associated with poorer hang wire performance. For the ﬁrst time,
our results demonstrate links between muscle ECM structure and physical function in obesity.
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INTRODUCTION
Skeletal muscle comprises 40–50% of body weight and is essential
for body movement, physical function and insulin-stimulated
glucose uptake, all of which are impaired in obesity. An essential
component of skeletal muscle is the extracellular matrix (ECM), the
non-cellular structure that provides scaffolding for muscle cells.
Mounting evidence demonstrates that the skeletal muscle ECM
is perturbed under obese and insulin-resistant conditions.1–4
Collagen abundance (total, collagens I and III) is higher in vastus
lateralis biopsies from obese insulin-resistant humans1 and in
diet-induced obese mice, insulin resistance and muscle collagen
(III and IV) deposition are rescued by pharmacological or genetic
manipulation targeting the ECM.3,4 Furthermore, a recently
published overfeeding study found dramatic upregulation of
mRNA levels in ECM genes (collagens I, III, IV, V and VI and SPARC)
in muscle from lean males after moderate weight gain.2 This body
of evidence suggests a new role for skeletal muscle ECM
remodelling in the pathophysiology of obesity and insulin
resistance. Whether muscle ECM is associated with impaired
physical function in obesity has not yet been investigated.
ECM homeostasis is a balance between synthesis and accumu-
lation of ECM components and ECM breakdown, with clear
evidence that ECM regulation strongly affects muscle function.5 In
normal muscle, the dystrophin–glycoprotein complex provides a
stabilizing connection between the actin membrane cytoskeleton
and the ECM component laminin. Mutations in genes encoding
several dystrophin components result in disruption of this
complex leading to muscular dystrophy.6 Given the emerging
role of muscle ECM remodelling in obesity and insulin resistance,
and known structure–function relationships in muscular
dystrophies,7 we investigated whether muscle ECM gene expres-
sion was associated with tests of anaerobic endurance and
co-ordination in obese mice.
MATERIALS AND METHODS
Mouse models
Six-week-old male C57BL/6 mice were purchased from the Animal
Resource Centre (Perth, WA, Australia). To examine the effect
of obesity on muscle function and ECM, mice were randomised to
chow (12% kcal fat content) or high-fat diet (HFD; 45% kcal fat
content) ad libitum for 5, 10 or 25 weeks. The HFD was prepared
in-house with a formula based on rodent diet no. D12451;
Research Diets (New Brunswick, NJ, USA). Insulin tolerance tests
were performed the week prior to termination. After a 4 h fast,
mice received an i.p. injection of human insulin (Actrapid) at a
dose of 0.65 IU per kg body weight. Blood glucose levels were
measured at 0, 5, 15, 30 and 60min post-insulin administration
from 10 μl of whole blood using a point of care blood glucose
monitoring system (Accu-Check Advantage, Roche Diagnostics,
Indianapolis, IN, USA). The excursion in blood glucose over time
was calculated as area under the curve (AUC) using the trapezoidal
method. For each curve generated, the change in AUC was
compared with the AUC obtained for the chow group (normalised
to 100%). At termination, gastrocnemius muscle was excised,
weighed and snap frozen in liquid nitrogen for gene expression
and protein analysis. Six independent experiments were per-
formed using this protocol and the data were combined across
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experiments. At 5, 10 and 25 weeks sample sizes were 9 chow vs
12 HFD, 11 chow vs 13 HFD and 11 chow vs 19 HFD. Investigators
were not blinded to the intervention. All mice in the HFD group
met the inclusion criteria of gaining ⩾ 5 g the average weight
gained by the chow group. This study was approved by the
Animal Ethics Committee of Sydney South West Area Health
Services, Australia.
Non-invasive muscle function tests
To assess muscle function, a series of non-invasive motor tests
(hang wire, hang mesh, grip strength) were performed in the week
prior to termination using standard operating protocols from the
Treat-NMD Neuromuscular Network.8 The hang wire tests whole
body anaerobic muscular endurance and co-ordination. Outputs
include the number of falls and reaches (up to a maximum of 10)
and the duration of hang time (up to a maximum of 180 s).
An aggregate score from the number of falls, reaches and time
metrics was derived using the formula: ([10 falls+reaches
+1] × time). The hang mesh was performed to test four limb
anaerobic muscular endurance. Grip strength was performed
to test maximal isometric forelimb grip strength. To adjust for
potential effects of body weight on test performance, results from
hang wire and hang mesh tests were multiplied by body weight.
Muscle function tests are further described in Supplementary
Data.
Real-time PCR measures
Total RNA was extracted using TRI reagent (Sigma-Aldrich,
St Louis, MO, USA). RNA amount and quality were determined
using a Nanodrop spectrophotometer (Nanodrop Technologies,
Wilmington, DE, USA). Total RNA (1μg) was then reverse-
transcribed to complementary DNA using 10 pmol of oligo
(dT)12–18 primer (Invitrogen, Carlsbad, CA, USA) and SuperScript
III reverse transcriptase (Invitrogen). Expression of genes related to
the ECM (collagen (COL)1, COL3, COL6A2, secreted protein acidic
and rich in cysteine (SPARC)), growth factors ((transforming growth
factor (TGFB)1, TGFB2, connective tissue growth factor (CTGF,
also known as CCN2), vascular endothelial growth factor (VEGF))
and muscle function (dystrophin (DMD (Dp147)), calpain 3
(CAPN3), β-dystroglycan (DAG1)) were measured using SensiMixII
(Bioline, Alexandria, NSW, Australia) and SYBR green ﬂuorophore
(Invitrogen). Primer sequences are listed in Supplementary
Table 1. Results are expressed as relative change from chow-fed
mice calculated using the delta–delta method and corrected for
the housekeeper 18S (23).
Protein analysis
For measurement of collagens 1, 3 and 6, 25 μg of total protein
per sample was loaded on 4–15% Mini-Protean TGX gels
(BioRad/BioRad Laboratories, Hercules, CA, USA). Membranes were
blocked for 1.5 h at room temperature with 5% skim milk in TBST,
and then incubated overnight at 4 °C with antibodies against
COL1 (AbCam, Cambridge, MA, USA; AB765P, 1:500), COL3
(AbCam, AB7778, 1:500) or COL6 (AbCam, AB6588, 1:5000). Goat
anti-rabbit secondary antibody (Sigma, Castle Hill, NSW, Australia;
AD545, 1:7000) was applied for 2 h at room temperature. Bands
were imaged with ChemiDoc MP system and quantiﬁed using
ImageLabTM software (Version 5.2, BioRad). Bands were normal-
ized to total lane protein (Ponceau staining) and inter-gel variation
was corrected using an internal control run across all gels.
Statistical analyses
Statistical analyses were performed using SPSS Version 22 (IBM
Corporation, Armonk, NY, USA) and GraphPad Prism 6 (GraphPad
Software Inc., La Jolla, CA, USA) and data presented as mean± s.d.
At each time-point, Mann–Whitney U-tests were performed to
investigate differences in physical function and gene expression
between chow and HFD groups and correlations were performed
using Pearson's coefﬁcient.
RESULTS
Reduced physical function in high-fat fed mice
As expected, HFD mice were signiﬁcantly heavier than chow-fed
mice at all time-points. Fasting blood glucose levels and excised
gastrocnemius weight were not different between groups
(Supplementary Table 2). At all time-points, HFD mice had
signiﬁcantly greater numbers of falls of the wire, less numbers
of reaches and less hanging time on the wire compared with
chow-fed mice (all Po0.001; data not shown). HFD mice had two
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Figure 1. Changes in muscle function after 5, 10 and 25 weeks of
high-fat diet. Muscle function tests include the (a) hang wire,
(b) hang mesh and (c) grip strength test. To account for potential
effects of body weight, hang wire and hang mesh results are
multiplied by body weight. At each time-point, Mann–Whitney
U-tests were performed to examine differences between chow and
high-fat fed mice. Data are presented as mean± s.e.m. **Po0.001;
Unﬁlled bars, chow; ﬁlled bars, high-fat diet.
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to six-fold lower hang wire scores (raw data and values adjusted
for body weight) compared with chow-fed mice (all Po0.001;
Figure 1). At 10 weeks, HFD mice also had lower hang mesh score
(median: chow= 4733; HFD= 2207; P= 0.04) and grip strength
(median: chow=2.0N; HFD= 1.7N; P= 0.0003) compared with
chow-fed mice. There were no signiﬁcant correlations between
hang wire, hang mesh and grip strength scores measured in the
same mice at all time-points (data not shown).
ECM gene expression and protein levels
COL1 (P= 0.002), COL3 (P= 0.02) and COL6 (P= 0.03) mRNA levels
were eight, three and four-fold lower, respectively, after 5 weeks
of HFD, compared with chow (Figure 2). These differences in COL1,
3 and 6 were not observed by protein analyses (Supplementary
Figure 1). No other signiﬁcant differences were observed for the
rest of the genes measured.
Associations between physical function and muscle ECM
Next we examined associations between measures of physical
function (hang wire, hang mesh, grip strength) and ECM gene
expression and protein levels. Interestingly, only in the HFD group,
higher COL3 (r=− 0.69, P= 0.02) and COL6 gene expression
(r=− 0.71, P= 0.03) were associated with poorer hang wire
performance at 5 weeks (Supplementary Figure 2). These
associations were not seen in chow-fed mice or after 10 and
25 weeks HFD. No associations were found between hang wire
or grip strength with ECM steady state mRNA levels, and no
associations were observed between physical function tests and
COL1, 3 and 6 protein levels at 5 weeks.
DISCUSSION
This study examined potential links between muscle ECM gene
expression and impaired physical function in obese mice. We
found that mice fed HFD for 5, 10 and 25 weeks had impaired
anaerobic endurance and co-ordination as measured by hang wire
test. These ﬁndings are in keeping with results in humans from
large cohort studies demonstrating the strong relationship
between elevated BMI and functional decline, where being
overweight or obese is associated with impairments in activities
of daily living.9–11 At 10 weeks, we also found lower hang mesh
and grip strength performance in the HFD group, which was not
evident at 25 weeks, suggesting a potential compensation effect
with a longer duration high-fat feeding.
Intriguingly, muscle ECM remodelling genes (COL1, 3 and 6)
were lower after 5 weeks HFD with no changes at subsequent
time-points. Our ﬁndings are somewhat in contrast to previous
studies demonstrating greater collagen deposition in skeletal
muscle from obese insulin-resistant adults1 and increased muscle
collagens 1 and 3 expression after 20 weeks HFD in mice.3 The
mice used in these studies did not exhibit signiﬁcant impairments
in insulin sensitivity or glucose homeostasis and if the HFD was
successful in generating insulin resistance as in previous mouse
studies,3,4 the ECM markers measured may have better mimicked
the human condition. However, interestingly we found associa-
tions between muscle ECM structure and function, with reduced
physical function (hang wire test) associated with greater COL3
and 6 expression only in the HFD group at 5 weeks; this ﬁnding
was not conﬁrmed at the protein level. The signiﬁcance of the
association seen at the level of gene expression only is unclear. It
may be that high-fat feeding affects muscle structure gene
regulation and muscle function, each in parallel, as we have
observed in this study, rather than structural changes mediating
functional changes. Future experiments using alternative mouse
strains, greater percent fat diets (445%) and shorter time courses
of high-fat feeding (o5 weeks) may assist in further elucidating
possible functional consequences of perturbed muscle ECM.
Alternatively, our ﬁnding of reduced COL1, COL3 and COL6
muscle expression after short-term HFD may indicate an
imbalance in ECM homeostasis. Investigations examining factors
that promote or inhibit the synthesis or degradation of the ECM
such as matrix metalloproteinases may provide further insight. In
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Figure 2. Changes in gastrocnemius mRNA levels in genes related to
(a) extracellular matrix remodelling, (b) extracellular matrix gene
regulation and (c) muscle function. Gene expression was calculated
using ΔΔCT and expressed as CHOW= 1 (represented by dotted
line). At each time-point, Mann–Whitney U-tests were performed to
examine differences between chow and high-fat fed mice. Empty
bars, 5 weeks; Striped bars, 10 weeks; Grey bars, 25 week time-point.
CAPN3, calpain 3; COL, collagen; CTGF, connective tissue growth
factor; DAG1, β-dystroglycan; DMD, dystrophin; SPARC, secreted
protein and rich in cysteine; TGF, transforming growth factor; VEGF,
vascular endothelial growth factor. *Po0.05, **Po0.001.
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conclusion, impaired physical motor skills in high-fat fed mice
were found in this study. The impairment was associated with
greater COL3 and COL6 gene expression in the gastrocnemius
muscle only after short-term HFD, suggesting that muscle
ECM expression can be linked to impaired physical function.
The muscle ECM may be a potential target for enhancing physical
function under obese conditions.
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